dc.contributor.author | Salduz, Ahmet | |
dc.contributor.author | Lewallen, David G. | |
dc.contributor.author | Sim, Franklin H. | |
dc.contributor.author | Rose, Peter S. | |
dc.contributor.author | Houdek, Matthew T. | |
dc.contributor.author | Abdel, Matthew P. | |
dc.contributor.author | Perry, Kevin I. | |
dc.date.accessioned | 2021-03-03T10:35:00Z | |
dc.date.available | 2021-03-03T10:35:00Z | |
dc.date.issued | 2020 | |
dc.identifier.citation | Houdek M. T. , Abdel M. P. , Perry K. I. , Salduz A., Rose P. S. , Sim F. H. , Lewallen D. G. , "Outcome of Patients Treated With Porous Tantalum Acetabular Implants for Neoplastic Periacetabular Lesions", JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS, cilt.28, sa.6, ss.256-262, 2020 | |
dc.identifier.issn | 1067-151X | |
dc.identifier.other | av_23706112-c44d-4886-b8cb-ca0734d7fba4 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/28768 | |
dc.identifier.uri | https://doi.org/10.5435/jaaos-d-18-00482 | |
dc.description.abstract | Introduction: The periacetabular region is a common location for nonprimary neoplastic tumors. Although these tumors were historically treated with a cemented acetabular implant, we previously reported on the short-term follow-up on the use of a tantalum acetabular shell to reconstruct these defects. This study expands our previous report on longer follow-up, with specific emphasis on patient and implant survivorship, radiographic results, and clinical outcomes. Methods: Fifty-eight patients (32 women and 26 men) were treated using a tantalum acetabular implant and total hip arthroplasty to reconstruct a nonprimary neoplastic process between 2001 and 2014. The mean age and body mass index were 62 years and 28 kg/m(2), respectively. The most common diagnosis was metastatic disease (n = 29). The patients' medical records and radiographs were reviewed to assess Harris hip scores and radiographic fixation. The mean follow-up for surviving patients was 8 years. Results: At the most recent follow-up, 41 patients were dead of the disease and 17 were alive with the disease and no cases of acetabular implant revision were reported. Two patients had a progressive radiolucent line; however, they also had radiographic evidence of local disease progression. After reconstruction, patients had a significant (P = 0.0001) increase in their Harris hip score (37 vs. 72). Discussion: In patients with periacetabular metastatic diseases and hematologic malignancies treated with total hip arthroplasty, a highly porous tantalum revision-type shell fixed with multiple screws, and supplemental support with acetabular augments or cup-cage reinforcement, can successfully provide patients with a stable, well-fixed, and durable construct, with no cases of mechanical failure at mid-term follow-up. | |
dc.language.iso | eng | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | CERRAHİ | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Cerrahi Tıp Bilimleri | |
dc.subject | Ortopedi ve Travmatoloji | |
dc.subject | ORTOPEDİ | |
dc.subject | Klinik Tıp | |
dc.title | Outcome of Patients Treated With Porous Tantalum Acetabular Implants for Neoplastic Periacetabular Lesions | |
dc.type | Makale | |
dc.relation.journal | JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS | |
dc.contributor.department | Mayo Clinic , , | |
dc.identifier.volume | 28 | |
dc.identifier.issue | 6 | |
dc.identifier.startpage | 256 | |
dc.identifier.endpage | 262 | |
dc.contributor.firstauthorID | 2278685 | |